Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

Roever L.
Resende E. S.
Diniz A. L. D.
Penha-Silva N.
O'Connell J. L.
Gomes P. F. S.
Zanetti H. R.
Roerver-Borges A. S.
Veloso F. C.
Fidale T. M.
Casella-Filho A.
Dourado P. M. M.
Chagas A. C. P.
Ali-Hasan-Al-Saegh S.
Reis P. E. O.
De Melo Pinto R.
Oliveira G. B. F.
Avezum A.
Neto M.
Duraes A.
Lisboa Da Silva R. M. F.
Grande A. J.
Denardi C.
Lopes R. D.
Nerlekar N.
Alizadeh S.
Hernandez A. V.
Biondi-Zoccai G.

January 2018

Background: Patients with HIV have been found to suffer from lipid abnormalities, including elevated...

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018

Teruel, Eva
Vandenhende, Marie-Anne
Neau, Didier
Lazaro, Estibaliz
Duffau, Pierre
Vareil, Marc-Olivier
Cazanave, Charles
Perrier, Adélaïde
Le Marec, Fabien
Leleux, Olivier
Bonnet, Fabrice
Wittkop, Linda

September 2021

International audienceObjectives: Bacterial infections remain one of the main causes of morbidity an...

Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Levy, Matthew E
Greenberg, Alan E
Magnus, Manya
Younes, Naji
Castel, Amanda

February 2018

Statin coverage has been examined among HIV-infected patients using Adult Treatment Panel III (ATP I...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

De Socio G. V.
Ricci E.
Parruti G.
Calza L.
Maggi P.
Celesia B. M.
Orofino G.
Madeddu G.
Martinelli C.
Menzaghi B.
Taramasso L.
Penco G.
Carenzi L.
Franzetti M.
Bonfanti P.

January 2016

Objectives: To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinic...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice : the results from HIV-HY study

G.V. De Socio
E. Ricci
G. Parruti
L. Calza
P. Maggi
B.M. Celesia
G. Orofino
G. Madeddu
C. Martinelli
B. Menzaghi
L. Taramasso
G. Penco
L. Carenzi
M. Franzetti
P. Bonfanti

October 2016

Objectives: To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinic...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio, Gv
Ricci, E
Parruti, G
Calza, Leonardo
Maggi, P
Celesia, Bm
Orofino, G
Madeddu, G
Martinelli, C
Menzaghi, B
Taramasso, L
Penco, G
Carenzi, L
Franzetti, M
Bonfanti, P.

January 2016

OBJECTIVES:To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinica...

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians

P. Maggi
G.V. De Socio
S. Cicalini
M. D&apos
G. Dettorre
A. Di Biagio
C. Martinelli
G. Nunnari
S. Rusconi
L. Sighinolfi
V. Spagnuolo
N. Squillace

April 2017

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin,...

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians

Maggi, Paolo
De Socio, Giuseppe Vittorio
Cicalini, Stefania
D'Abbraccio, Maurizio
Dettorre, Gabriella
Di Biagio, Antonio
Martinelli, Canio
Nunnari, Giuseppe
Rusconi, Stefano
Sighinolfi, Laura
Spagnuolo, Vincenzo
Squillace, Nicola

January 2017

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin,...

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: Review of the literature and suggestions for a friendly use

P. Maggi
G.V. De Socio
S. Cicalini
M. D&apos
G. Dettorre
A. Di Biagio
C. Martinelli
G. Nunnari
S. Rusconi
L. Sighinolfi
V. Spagnuolo
N. Squillace

May 2019

Background: As in non-infected subjects, statins and aspirin have a pivotal preventive role in reduc...

Patients living with HIV infection are less likely to receive the correct statin intensity for cardiovascular disease risk reduction

Schafer, PharmD, MPH, Jason J.
Emmons, PharmD, BCPS, Roshni
Hastain, PharmD, Nick V.
Miano, PharmD, PhD, Todd

October 2019

Patients living with HIV (PLWH) are at high risk for atherosclerotic cardiovascular disease (ASCVD) ...

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients

Sujit Suchindran Susan

September 2016

Background. Human immunodeficiency virus (HIV) infection is associated with increased risk of myocar...

Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

Rasmussen Line D.
Kronborg Gitte
Larsen Carsten S.
Pedersen Court
Gerstoft Jan
Obel Niels

March 2013

Recent studies have suggested that statins possess diverse immune modulatory and anti-inflammatory p...

Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.

Line D Rasmussen
Gitte Kronborg
Carsten S Larsen
Court Pedersen
Jan Gerstoft
Niels Obel

BACKGROUND: Recent studies have suggested that statins possess diverse immune modulatory and anti-in...

CLINICAL SCIENCE Prescribing of Contraindicated Protease Inhibitor and Statin Combinations Among HIV-Infected Persons

Todd Hulgan

January 2015

Summary: HIV-1 protease inhibitors (PIs) contribute to hyperlip-idemia in persons treated for HIV in...

Are patients living with HIV infection at risk for not receiving statin medications for cardiovascular disease risk reduction?

Hastain, PharmD Candidate, Nick
Patel, PharmD, BCPS, Roshni S.
Schafer, PharmD, MPH, BCPS, AAHIVP, Jason J.

December 2018

Objective To determine the prevalence of appropriate statin prescribing for ASCVD risk reduction in ...

Statins in adult patients with HIV

Roever L.
Resende E. S.
Diniz A. L. D.
Penha-Silva N.
O'Connell J. L.
Gomes P. F. S.
Zanetti H. R.
Roerver-Borges A. S.
Veloso F. C.
Fidale T. M.
Casella-Filho A.
Dourado P. M. M.
Chagas A. C. P.
Ali-Hasan-Al-Saegh S.
Reis P. E. O.
De Melo Pinto R.
Oliveira G. B. F.
Avezum A.
Neto M.
Duraes A.
Lisboa Da Silva R. M. F.
Grande A. J.
Denardi C.
Lopes R. D.
Nerlekar N.
Alizadeh S.
Hernandez A. V.
Biondi-Zoccai G.

January 2018

Background: Patients with HIV have been found to suffer from lipid abnormalities, including elevated...

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018

Teruel, Eva
Vandenhende, Marie-Anne
Neau, Didier
Lazaro, Estibaliz
Duffau, Pierre
Vareil, Marc-Olivier
Cazanave, Charles
Perrier, Adélaïde
Le Marec, Fabien
Leleux, Olivier
Bonnet, Fabrice
Wittkop, Linda

September 2021

International audienceObjectives: Bacterial infections remain one of the main causes of morbidity an...

Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Levy, Matthew E
Greenberg, Alan E
Magnus, Manya
Younes, Naji
Castel, Amanda

February 2018

Statin coverage has been examined among HIV-infected patients using Adult Treatment Panel III (ATP I...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

De Socio G. V.
Ricci E.
Parruti G.
Calza L.
Maggi P.
Celesia B. M.
Orofino G.
Madeddu G.
Martinelli C.
Menzaghi B.
Taramasso L.
Penco G.
Carenzi L.
Franzetti M.
Bonfanti P.

January 2016

Objectives: To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinic...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice : the results from HIV-HY study

G.V. De Socio
E. Ricci
G. Parruti
L. Calza
P. Maggi
B.M. Celesia
G. Orofino
G. Madeddu
C. Martinelli
B. Menzaghi
L. Taramasso
G. Penco
L. Carenzi
M. Franzetti
P. Bonfanti

October 2016

Objectives: To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinic...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study.

De Socio, Gv
Ricci, E
Parruti, G
Calza, Leonardo
Maggi, P
Celesia, Bm
Orofino, G
Madeddu, G
Martinelli, C
Menzaghi, B
Taramasso, L
Penco, G
Carenzi, L
Franzetti, M
Bonfanti, P.

January 2016

OBJECTIVES:To investigate the use of statins and acetylsalicylic acid (ASA) in HIV people in clinica...

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients : a survey among Italian HIV physicians

P. Maggi
G.V. De Socio
S. Cicalini
M. D&apos
G. Dettorre
A. Di Biagio
C. Martinelli
G. Nunnari
S. Rusconi
L. Sighinolfi
V. Spagnuolo
N. Squillace

April 2017

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin,...

Use of statins and aspirin to prevent cardiovascular disease among HIV-positive patients. A survey among Italian HIV physicians

Maggi, Paolo
De Socio, Giuseppe Vittorio
Cicalini, Stefania
D'Abbraccio, Maurizio
Dettorre, Gabriella
Di Biagio, Antonio
Martinelli, Canio
Nunnari, Giuseppe
Rusconi, Stefano
Sighinolfi, Laura
Spagnuolo, Vincenzo
Squillace, Nicola

January 2017

We conducted a survey among Italian HIV specialists to study the utilization of statins and aspirin,...

Statins and aspirin in the prevention of cardiovascular disease among HIV-positive patients between controversies and unmet needs: Review of the literature and suggestions for a friendly use

P. Maggi
G.V. De Socio
S. Cicalini
M. D&apos
G. Dettorre
A. Di Biagio
C. Martinelli
G. Nunnari
S. Rusconi
L. Sighinolfi
V. Spagnuolo
N. Squillace

May 2019

Background: As in non-infected subjects, statins and aspirin have a pivotal preventive role in reduc...

Patients living with HIV infection are less likely to receive the correct statin intensity for cardiovascular disease risk reduction

Schafer, PharmD, MPH, Jason J.
Emmons, PharmD, BCPS, Roshni
Hastain, PharmD, Nick V.
Miano, PharmD, PhD, Todd

October 2019

Patients living with HIV (PLWH) are at high risk for atherosclerotic cardiovascular disease (ASCVD) ...

Aspirin Use for Primary and Secondary Prevention in Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Patients

Sujit Suchindran Susan

September 2016

Background. Human immunodeficiency virus (HIV) infection is associated with increased risk of myocar...

Statin Therapy and Mortality in HIV-Infected Individuals; A Danish Nationwide Population-Based Cohort Study

Rasmussen Line D.
Kronborg Gitte
Larsen Carsten S.
Pedersen Court
Gerstoft Jan
Obel Niels

March 2013

Recent studies have suggested that statins possess diverse immune modulatory and anti-inflammatory p...

Statin therapy and mortality in HIV-infected individuals; a Danish nationwide population-based cohort study.

Line D Rasmussen
Gitte Kronborg
Carsten S Larsen
Court Pedersen
Jan Gerstoft
Niels Obel

BACKGROUND: Recent studies have suggested that statins possess diverse immune modulatory and anti-in...

CLINICAL SCIENCE Prescribing of Contraindicated Protease Inhibitor and Statin Combinations Among HIV-Infected Persons

Todd Hulgan

January 2015

Summary: HIV-1 protease inhibitors (PIs) contribute to hyperlip-idemia in persons treated for HIV in...

Are patients living with HIV infection at risk for not receiving statin medications for cardiovascular disease risk reduction?

Hastain, PharmD Candidate, Nick
Patel, PharmD, BCPS, Roshni S.
Schafer, PharmD, MPH, BCPS, AAHIVP, Jason J.

December 2018

Objective To determine the prevalence of appropriate statin prescribing for ASCVD risk reduction in ...

Statins in adult patients with HIV

Roever L.
Resende E. S.
Diniz A. L. D.
Penha-Silva N.
O'Connell J. L.
Gomes P. F. S.
Zanetti H. R.
Roerver-Borges A. S.
Veloso F. C.
Fidale T. M.
Casella-Filho A.
Dourado P. M. M.
Chagas A. C. P.
Ali-Hasan-Al-Saegh S.
Reis P. E. O.
De Melo Pinto R.
Oliveira G. B. F.
Avezum A.
Neto M.
Duraes A.
Lisboa Da Silva R. M. F.
Grande A. J.
Denardi C.
Lopes R. D.
Nerlekar N.
Alizadeh S.
Hernandez A. V.
Biondi-Zoccai G.

January 2018

Background: Patients with HIV have been found to suffer from lipid abnormalities, including elevated...

Statin use and risk of severe bacterial infection in a population living with HIV: prospective cohort study of the ANRS CO3 Aquitaine Cohort 2000–2018

Teruel, Eva
Vandenhende, Marie-Anne
Neau, Didier
Lazaro, Estibaliz
Duffau, Pierre
Vareil, Marc-Olivier
Cazanave, Charles
Perrier, Adélaïde
Le Marec, Fabien
Leleux, Olivier
Bonnet, Fabrice
Wittkop, Linda

September 2021

International audienceObjectives: Bacterial infections remain one of the main causes of morbidity an...

Evaluation of Statin Eligibility, Prescribing Practices, and Therapeutic Responses Using ATP III, ACC/AHA, and NLA Dyslipidemia Treatment Guidelines in a Large Urban Cohort of HIV-Infected Outpatients.

Levy, Matthew E
Greenberg, Alan E
Magnus, Manya
Younes, Naji
Castel, Amanda

February 2018

Statin coverage has been examined among HIV-infected patients using Adult Treatment Panel III (ATP I...

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

Abstract

Extracted data

Statins and Aspirin use in HIV-infected people: gap between European AIDS Clinical Society guidelines and clinical practice: the results from HIV-HY study

Abstract

Extracted data

Related items

Related items